What is Cirdan?
Established in 2010 and headquartered in the UK, Cirdan is a prominent provider of informatics software and imaging solutions designed to accelerate and improve patient diagnoses. With a global presence extending to Canada and Australia, Cirdan is recognized as a leading supplier of laboratory information systems worldwide. The company's offerings are crucial for enhancing the efficiency and accuracy of diagnostic processes within healthcare systems.
How much funding has Cirdan raised?
Cirdan has raised a total of $16M across 3 funding rounds:
Private Equity
$4.2M
Other Financing Round
$2.8M
Other Financing Round
$9M
Private Equity (2016): $4.2M with participation from Kainos Group plc
Other Financing Round (2023): $2.8M led by Kernel Capital and Clarendon Fund Managers
Other Financing Round (2024): $9M supported by Kernel Capital
Key Investors in Cirdan
Kernel Capital
Kernel Capital is a venture capital and private equity firm specializing in growth and early-stage companies, offering both capital and strategic guidance to foster scaling and successful exits. They primarily serve technology and innovation-driven businesses.
Clarendon Fund Managers
Clarendon Fund Managers manages Co-Fund NI, an initiative providing equity finance to Northern Irish businesses with growth aspirations. They invest alongside private backers, focusing on SMEs with growth potential and typically investing in rounds between £150,000 and £1,000,000.
Kainos Group plc
Kainos Group plc is a digital services company providing technology solutions for cloud transformation, digital platforms, and data-driven innovation. They assist organizations in modernizing systems and improving operational efficiency through software development and consulting.
What's next for Cirdan?
The substantial enterprise-level funding Cirdan has attracted positions it for significant expansion and innovation. This capital injection is expected to fuel further development of its informatics software and imaging solutions, potentially leading to market share growth and the exploration of new diagnostic frontiers. The company's strategic focus will likely involve enhancing its global reach and solidifying its leadership in laboratory information systems, leveraging this investment to drive technological advancements and operational scaling.
See full Cirdan company page
